...
首页> 外文期刊>Cancer Cell International >Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2eu receptors of breast carcinoma tissues with derived cell lines
【24h】

Establishment and characterization of two human breast carcinoma cell lines by spontaneous immortalization: Discordance between Estrogen, Progesterone and HER2eu receptors of breast carcinoma tissues with derived cell lines

机译:通过自发永生化建立和表征两种人类乳腺癌细胞系:乳腺癌组织中雌激素,孕酮和HER2 / neu受体与衍生细胞系之间的不一致

获取原文
           

摘要

Breast cancer is one of the most common cancers among women throughout the world. Therefore, established cell lines are widely used as in vitro experimental models in cancer research. Two continuous human breast cell lines, designated MBC1 and MBC2, were successfully established and characterized from invasive ductal breast carcinoma tissues of Malaysian patients. MBC1 and MBC2 have been characterized in terms of morphology analysis, population doubling time, clonogenic formation, wound healing assay, invasion assay, cell cycle, DNA profiling, fluorescence immunocytochemistry, Western blotting and karyotyping. MBC1 and MBC2 exhibited adherent monolayer epithelial morphology at a passage number of 150. Receptor status of MBC1 and MBC2 show (ER+, PR+, HER2+) and (ER+, PR-, HER2+), respectively. These results are in discordance with histopathological studies of the tumoral tissues, which were triple negative and (ER-, PR-, HER2+) for MBC1 and MBC2, respectively. Both cell lines were capable of growing in soft agar culture, which suggests their metastatic potential. The MBC1 and MBC2 metaphase spreads showed an abnormal karyotype, including hyperdiploidy and complex rearrangements with modes of 52–58 chromosomes per cell. Loss or gain in secondary properties, deregulation and specific genetic changes possibly conferred receptor changes during the culturing of tumoral cells. Thus, we hypothesize that, among heterogenous tumoral cells, only a small minority of ER+/PR+/HER2+ and ER+/PR-/HER2+ cells with lower energy metabolism might survive and adjust easily to in vitro conditions. These cell lines will pave the way for new perspectives in genetic and biological investigations, drug resistance and chemotherapy studies, and would serve as prototype models in Malaysian breast carcinogenesis investigations.
机译:乳腺癌是全世界女性中最常见的癌症之一。因此,已建立的细胞系被广泛用作癌症研究中的体外实验模型。从马来西亚患者的浸润性导管癌组织中成功建立了两个连续的人乳腺癌细胞系,命名为MBC1和MBC2。 MBC1和MBC2已在形态分析,群体倍增时间,克隆形成,伤口愈合测定,侵袭测定,细胞周期,DNA谱,荧光免疫细胞化学,蛋白质印迹和核型分析方面进行了表征。 MBC1和MBC2在传代数为150时表现出粘附的单层上皮形态。MBC1和MBC2的受体状态分别显示(ER +,PR +,HER2 +)和(ER +,PR-,HER2 +)。这些结果与肿瘤组织的组织病理学研究不一致,肿瘤组织的MBC1和MBC2分别为三阴性和(ER-,PR-,HER2 +)。两种细胞系均能够在软琼脂培养物中生长,这表明它们具有转移潜力。 MBC1和MBC2中期扩散显示出异常的核型,包括超二倍体和复杂的重排,每个细胞有52–58个染色体。在肿瘤细胞的培养过程中,次要特性的丧失或获得,失调和特定的遗传变化可能使受体发生变化。因此,我们假设,在异源性肿瘤细胞中,只有少数能量代谢较低的ER + / PR + / HER2 +和ER + / PR- / HER2 +细胞可以存活并易于适应体外条件。这些细胞系将为遗传和生物学研究,耐药性和化学疗法研究的新观点铺平道路,并将作为马来西亚乳腺癌致癌研究的原型模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号